Sleep apnea is a serious medical condition with significant health consequences. Treatment with positive airway pressure (PAP) therapy is effective, but adherence to treatment is poor. Lower adherence can result in undertreated patients and, in some cases, may lead to refusal of insurers to pay for therapy.
DreamMapper is a mobile application and website that employs theoretically driven and empirically tested interventions designed to improve adherence to PAP therapy.
Download Philips Respironics’ newest white paper to learn more about how you can use DreamMapper to improve patient treatment plans.
CLICK IMAGE TO DOWNLOAD
Whitepaper courtesy of